Metropolitan Life Insurance CO Inhibrx, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.75 - $26.31 $2,205 - $3,683	140 Added 7.73%	1,950 $35,000
Q1 2023 May 15, 2023	SELL	$18.45 - $27.14 $5,018 - $7,382	-272 Reduced 13.06%	1,810 $34,000
Q4 2022 Jun 14, 2023	BUY	$20.18 - $33.33 $5,488 - $9,065	272 Added 15.03%	2,082 $51.3 Million
Q3 2022 Jun 14, 2023	BUY	$11.58 - $24.73 $3,149 - $6,726	272 Added 15.03%	2,082 $37.4 Million
Q2 2022 Jun 20, 2023	BUY	$8.52 - $25.26 $2,317 - $6,870	272 Added 15.03%	2,082 $23,000
Q1 2022 Jun 20, 2023	BUY	$19.89 - $43.18 $5,410 - $11,744	272 Added 15.03%	2,082 $46,000
Q1 2022 Mar 30, 2023	SELL	$19.89 - $43.18 $113,452 - $246,298	-5,704 Reduced 73.26%	2,082 $46,000
Q1 2022 May 12, 2022	SELL	$19.89 - $43.18 $113,452 - $246,298	-5,704 Reduced 73.26%	2,082 $46,000
Q4 2021 Jun 21, 2023	BUY	$26.75 - $46.02 $159,858 - $275,015	5,976 Added 330.17%	7,786 $340,000
Q4 2021 Mar 30, 2023	SELL	$26.75 - $46.02 $27,713 - $47,676	-1,036 Reduced 11.74%	7,786 $340,000
Q4 2021 Feb 15, 2022	SELL	$26.75 - $46.02 $27,713 - $47,676	-1,036 Reduced 11.74%	7,786 $340,000
Q3 2021 Jun 21, 2023	BUY	$25.18 - $37.81 $176,562 - $265,123	7,012 Added 387.4%	8,822 $293,000
Q2 2021 Jun 21, 2023	BUY	$14.69 - $27.52 $103,006 - $192,970	7,012 Added 387.4%	8,822 $242,000
Q2 2021 Mar 30, 2023	BUY	$14.69 - $27.52 $88,918 - $166,578	6,053 Added 218.6%	8,822 $242,000
Q2 2021 Aug 16, 2021	BUY	$14.69 - $27.52 $129,595 - $242,781	8,822 New	8,822 $243,000
Q1 2021 May 14, 2021	SELL	$16.27 - $41.26 $45,051 - $114,248	-2,769 Closed	0 $0
Q4 2020 Jun 22, 2023	BUY	$15.96 - $50.0 $15,305 - $47,950	959 Added 52.98%	2,769 $91,000
Q4 2020 Mar 30, 2023	BUY	$15.96 - $50.0 $10,964 - $34,350	687 Added 33.0%	2,769 $91,000
Q4 2020 Feb 16, 2021	BUY	$15.96 - $50.0 $44,193 - $138,450	2,769 New	2,769 $91,000

Others Institutions Holding INBX

# of Institutions

Shares Held

25.3K

Call Options Held

Put Options Held

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $617M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account